Molecular Partners Reports 1H Results
Molecular Partners H1 Net Loss Narrows, Revenue Rises
Molecular Partners Adjusted H1 EPS $(0.88), Sales $4.75M
Molecular | 6-K: Report of foreign private issuer (related to financial reporting)
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Smith & Wesson Brands, Abacus Life And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit
Wholesale Prices Tick Down in May as US Equity Futures Point to Premarket Losses
Market-Moving News for June 14th
12 Health Care Stocks Moving In Friday's Pre-Market Session
Molecular Partners Shares Are Trading Higher After the Comapny Announced Preclinical Proof-of-concept Data From MP0621.
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Top Premarket Gainers
Market-Moving News for June 11th
No Data
No Data